相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Enzymatic Activity of Lysyl Oxidas-like-2 (LOXL2) Is Not Required for LOXL2-induced Inhibition of Keratinocyte Differentiation
Jennie Lugassy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
被撤回的出版物: Lysyl Oxidase-like 2 Deaminates Lysine 4 in Histone H3 (Retracted article. See vol. 63, pg. 180, 2016)
Nicolas Herranz et al.
MOLECULAR CELL (2012)
Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesions
C-R Pradeep et al.
ONCOGENE (2012)
Monitoring antivascular therapy in head and neck cancer xenografts using contrast-enhanced MR and US imaging
Mukund Seshadri et al.
ANGIOGENESIS (2011)
Lysyl oxidase-like protein-2 regulates sprouting angiogenesis and type IV collagen assembly in the endothelial basement membrane
Marine Bignon et al.
BLOOD (2011)
LOXL2-Mediated Matrix Remodeling in Metastasis and Mammary Gland Involution
Holly E. Barker et al.
CANCER RESEARCH (2011)
Lysyl oxidase-like 2 (LOXL2), a new regulator of cell polarity required for metastatic dissemination of basal-like breast carcinomas
Gema Moreno-Bueno et al.
EMBO MOLECULAR MEDICINE (2011)
NORMALIZATION OF THE VASCULATURE FOR TREATMENT OF CANCER AND OTHER DISEASES
Shom Goel et al.
PHYSIOLOGICAL REVIEWS (2011)
Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation
Carmen Chak-Lui Wong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The Lysyl Oxidases LOX and LOXL2 Are Necessary and Sufficient to Repress E-cadherin in Hypoxia INSIGHTS INTO CELLULAR TRANSFORMATION PROCESSES MEDIATED BY HIF-1
Ruth Schietke et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Modulation of Lysyl Oxidase-like 2 Enzymatic Activity by an Allosteric Antibody Inhibitor
Hector M. Rodriguez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment
Vivian Barry-Hamilton et al.
NATURE MEDICINE (2010)
A novel asymmetric 3D in-vitro assay for the study of tumor cell invasion
Vera Brekhman et al.
BMC CANCER (2009)
Hypoxia-Induced Lysyl Oxidase Is a Critical Mediator of Bone Marrow Cell Recruitment to Form the Premetastatic Niche
Janine T. Erler et al.
CANCER CELL (2009)
Secreted LOXL2 is a novel therapeutic target that promotes gastric cancer metastasis via the Src/FAK pathway
Liang Peng et al.
CARCINOGENESIS (2009)
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
Kandice R. Levental et al.
CELL (2009)
Matrigel cytometry: A novel method for quantifying angiogenesis in vivo
A. Adini et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2009)
Semaphorin-3B is an angiogenesis inhibitor that is inactivated by furin-like pro-protein convertases
Asya Varshavsky et al.
CANCER RESEARCH (2008)
Lysyl oxidase-like 2 as a new poor prognosis marker of squamous cell carcinomas
Hector Peinado et al.
CANCER RESEARCH (2008)
VE-statin/egfl7 regulates vascular elastogenesis by interacting with lysyl oxidases
Etienne Lelievre et al.
EMBO JOURNAL (2008)
The tumor microenvironment and its contribution to tumor evolution toward metastasis
Girieca Lorusso et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2008)
Successful Inhibition of Tumor Development by Specific Class-3 Semaphorins Is Associated with Expression of Appropriate Semaphorin Receptors by Tumor Cells
Boaz Kigel et al.
PLOS ONE (2008)
Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells
Farbod Shojaei et al.
NATURE BIOTECHNOLOGY (2007)
Lysyl oxidase-like 2 expression is increased in colon and esophageal tumors and associated with less differentiated colon tumors
Sheri F. T. Fong et al.
GENES CHROMOSOMES & CANCER (2007)
Myeloid cell trafficking and tumor angiogenesis
Michael C. Schmid et al.
CANCER LETTERS (2007)
Targeted anti-vascular endothelial growth factor receptor-2 therapy leads to short-term and long-term impairment of vascular function and increase in tumor hypoxia
M Franco et al.
CANCER RESEARCH (2006)
Lysyl oxidase regulates breast cancer cell migration and adhesion through a hydrogen peroxide-mediated mechanism
SL Payne et al.
CANCER RESEARCH (2005)
Endothelial extracellular matrix - Biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization
GE Davis et al.
CIRCULATION RESEARCH (2005)
A molecular role for lysyl oxidase-like 2 enzyme in Snail regulation and tumor progression
H Peinado et al.
EMBO JOURNAL (2005)
Abnormal deposition of collagen around hepatocytes in Wilson's disease is associated with hepatocyte specific expression of lysyl oxidase and lysyl oxidase like protein-2
Z Vadasz et al.
JOURNAL OF HEPATOLOGY (2005)
Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy
RK Jain
SCIENCE (2005)
Semaphorin-3F is an inhibitor of tumor angiogenesis
O Kessler et al.
CANCER RESEARCH (2004)
Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors
RT Tong et al.
CANCER RESEARCH (2004)
The presence of a fibrotic focus in invasive breast carcinoma correlates with the expression of carbonic anhydrase IX and is a marker of hypoxia and poor prognosis
CG Colpaert et al.
BREAST CANCER RESEARCH AND TREATMENT (2003)
Lysyl oxidase: Properties, specificity, and biological roles inside and outside of the cell
HM Kagan et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2003)
Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer
CJ Kuo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Glomeruloid microvascular proliferation follows adenoviral vascular permeability factor/vascular endothelial growth factor-164 gene delivery
C Sundberg et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Spatial relationship between hypoxia and the (perfused) vascular network in a human glioma xenograft: A quantitative multi-parameter analysis
PFJW Rijken et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2000)
分享论文
